Cegedim Share Price

Equities

CGM

FR0000053506

Software

Real-time Euronext Paris 02:53:57 20/05/2024 pm IST 5-day change 1st Jan Change
13.95 EUR -0.71% Intraday chart for Cegedim -1.06% -21.89%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 652M 709M 59.05B Sales 2025 * 690M 750M 62.5B Capitalization 191M 207M 17.28B
Net income 2024 * 21M 22.83M 1.9B Net income 2025 * 24M 26.09M 2.17B EV / Sales 2024 * 0.57 x
Net Debt 2024 * 182M 198M 16.52B Net Debt 2025 * 155M 168M 14.01B EV / Sales 2025 * 0.5 x
P/E ratio 2024 *
9.83 x
P/E ratio 2025 *
8.57 x
Employees 6,411
Yield 2024 *
3.91%
Yield 2025 *
2.49%
Free-Float 42.73%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.71%
1 week-1.06%
Current month-3.12%
1 month+1.82%
3 months-14.84%
6 months-28.02%
Current year-21.89%
More quotes
1 week
13.95
Extreme 13.95
14.45
1 month
13.30
Extreme 13.3
14.95
Current year
11.30
Extreme 11.3
18.80
1 year
11.30
Extreme 11.3
23.55
3 years
11.30
Extreme 11.3
29.80
5 years
11.30
Extreme 11.3
33.20
10 years
11.30
Extreme 11.3
44.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 81 27/69/27
Director of Finance/CFO - 14/16/14
Director/Board Member 53 01/95/01
Members of the board TitleAgeSince
Chief Executive Officer 81 27/69/27
Director/Board Member 67 14/16/14
Director/Board Member 70 01/84/01
More insiders
Date Price Change Volume
20/24/20 13.95 -0.71% 1 386
17/24/17 14.05 -0.35% 403
16/24/16 14.1 -1.74% 4,708
15/24/15 14.35 +1.06% 3,117
14/24/14 14.2 +0.71% 3,836

Real-time Euronext Paris, May 20, 2024 at 02:53 pm IST

More quotes
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (72.1%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (26.8%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (1.1%). France accounts for 89.7% of net sales.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
14.05 EUR
Average target price
18.03 EUR
Spread / Average Target
+28.35%
Consensus

Quarterly revenue - Rate of surprise

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW